• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    Pharmaceuticals & Biotech.
    Pharmaceuticals & Biotech.
    SECTOR | 02 May 2023

    Strong volume growth in the domestic formulation business and healthy product launch pipeline

    buy
    Pharmaceuticals & Biotech.
    by KRChoksey
    KRChoksey
    Indian Pharma Market (IPM) reported 11.9% YoY growth in sales in Q4FY23, as expected, driven by 3.5% and 5.8% YoY growth in volumes and realisation respectively. While growth from the new product launches was around 2.5% YoY.
    Copy Link Share on Share on Share on Share on
    Alert  
    More from Pharmaceuticals & Biotech.
    Recommended
    Five Interesting Stocks Today - June 27, 2025
    The Baseline | 27 Jun 2025, 05:49PM
    Market closes higher, Ahluwalia bags Rs 1,103.6 crore residential projects in Gurugram and Bengaluru
    Trendlyne Marketwatch | 27 Jun 2025, 03:57PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd